Filing Details

Accession Number:
0001209191-10-010848
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-19 12:00:00
Reporting Period:
2010-02-17
Filing Date:
2010-02-19
Accepted Time:
2010-02-19 16:07:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp C/O Ra Capital Management, Llc
20 Park Plaza, Suite 905
Boston MA 02116
No No Yes No
1346824 Ra Capital Management, Llc C/O Ra Capital Management, Llc
20 Park Plaza, Suite 905
Boston MA 02116
No No Yes No
1384859 Peter Kolchinsky C/O Ra Capital Management, Llc
20 Park Plaza, Suite 905
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-17 50,000 $29.05 658,770 No 4 S Indirect see footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect see footnote
Footnotes
  1. These shares represent 536,778 shares held by RA Capital Healthcare Fund, L.P. ("Fund I") and 121,992 shares held by Blackwell Partners, LLC ("Blackwell").
  2. RA Capital Management, LLC (the "Adviser") is the general partner of Fund I and the investment adviser of Blackwell. Peter Kolchinsky is the sole manager of the Adviser. Each of the Reporting Persons disclaims beneficial ownership of any shares of the above names Issuer reported herein, except to the extent of his or its pecuniary interest therein.